Singing River Health System and Renalytix announced a partnership to deploy KidneyIntelX™ informed care management to improve kidney health in individuals with type 2 diabetes and early-stage chronic kidney disease. The Renalytix KidneyIntelX platform enables Singing River's primary and specialty care providers to easily identify and understand a person's kidney health risks, implement medication and nutrition management, and provide educational intervention on a timely basis. Singing River is a mission-driven healthcare provider with locations spanning across the Mississippi Gulf Coast, a region with one of the rates of diabetes in the country.

The partnership between Singing River and Renalytix will focus on improving health outcomes and reducing healthcare costs in this high-risk population by driving early detection and providing informed care in seeking to delay disease progression and prevent unnecessary dialysis starts. Approximately 25% of Mississippi's 3 million residents are currently enrolled in Medicaid health benefits. Reports estimate the state's direct and indirect costs of diabetes and its associated conditions like chronic kidney disease can be as high as $3.4 billion annually, creating an urgent need for Singing River Health System to utilize innovative technologies to delay and prevent chronic disease progression in this population.

Recent data also shows that Mississippi continues to be one of the worst states at providing better outcomes and access to healthcare in the Black and Latinx communities, who are already at an increased risk of developing diabetes and chronic kidney disease. Singing River Health System is the first partner located along the Gulf Coast for Renalytix. The health system expansion of KidneyIntelX is also supported by the recent launch within the General Services Administration, which has granted a 10-year government-wide contract for KidneyIntelX.

KidneyIntelX is also covered under various commercial insurance programs.